A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine

C Kloypan, N Koomdee, P Satapornpong, T Tempark… - Pharmaceuticals, 2021 - mdpi.com
Human leukocyte antigen (HLA) encoded by the HLA gene is an important modulator for
immune responses and drug hypersensitivity reactions as well. Genetic polymorphisms of …

[HTML][HTML] Tumor lysis syndrome: a clinical review

AE Mirrakhimov, P Voore, M Khan… - World Journal of Critical …, 2015 - ncbi.nlm.nih.gov
Tumor lysis syndrome is an oncometabolic emergency resulting from rapid cell death. Tumor
lysis syndrome can occur as a consequence of tumor targeted therapy or spontaneously …

Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan

CY Yang, CH Chen, ST Deng, CS Huang… - JAMA internal …, 2015 - jamanetwork.com
Importance Allopurinol, a first-line drug used for treating gout, is increasingly prescribed
worldwide to patients with asymptomatic hyperuricemia and comorbid renal or …

Drugs in clinical development to treat autosomal dominant polycystic kidney disease

T Bais, RT Gansevoort, E Meijer - Drugs, 2022 - Springer
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive
cyst formation that ultimately leads to kidney failure in most patients. Approximately 10% of …

Kidney disease in adenine phosphoribosyltransferase deficiency

HL Runolfsdottir, R Palsson, IM Agustsdottir… - American Journal of …, 2016 - Elsevier
Background Adenine phosphoribosyltransferase (APRT) deficiency is a purine metabolism
disorder causing kidney stones and chronic kidney disease (CKD). The course of …

Xanthine oxidase inhibitors for improving renal function in chronic kidney disease patients: an updated systematic review and meta-analysis

A Pisano, V Cernaro, G Gembillo, G D'Arrigo… - International journal of …, 2017 - mdpi.com
Background: Accruing evidence suggests that Xanthine Oxidase inhibitors (XOis) may bring
direct renal benefits, besides those related to their hypo-uricemic effect. We hence aimed at …

Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease

Y Tsuruta, T Mochizuki, T Moriyama, M Itabashi… - Clinical …, 2014 - Springer
Hyperuricemia is a frequent complication of chronic kidney disease (CKD). Febuxostat is a
novel xanthine oxidase inhibitor that is metabolized by many metabolic pathways in the …

[PDF][PDF] Urate lowering therapies in the treatment of gout: a systematic review and meta-analysis.

C BORGHI, F Perez-Ruiz - European Review for Medical & …, 2016 - europeanreview.org
OBJECTIVE: In patients with gout, serum uric acid (sUA) concentrations should be lowered
at least below the target of 6 mg/dL (even below 5 mg/dL in patients with severe gout). To …

[HTML][HTML] Combination of allopurinol with Dahuang Mudan Tang (大黄牡丹汤) significantly improve kidney function and alleviate oxidative stress and inflammation of …

F Congcong, ZHU Xiaoliang, Y ZHANG… - Journal of Traditional …, 2024 - ncbi.nlm.nih.gov
OBJECTIVE: To evaluate the effect of Dahuang Mudan Tang (大黄牡丹汤, DHMD) and
allopurinol on the treatment of chronic kidney disease staged G1-G3b patients with …

[PDF][PDF] Allopurinol against progression of chronic kidney disease

S Golmohammadi, A Almasi… - Iranian journal of …, 2017 - academia.edu
Allopurinol Against Progression of Chronic Kidney Disease Page 1 KIDNEY DISEASES 286
Original P aper Iranian Journal of Kidney Diseases | Volume 11 | Number 4 | July 2017 …